154 related articles for article (PubMed ID: 38779903)
1. NSAIDs for early management of acute respiratory infections.
Bassetti M; Andreoni M; Santus P; Scaglione F
Curr Opin Infect Dis; 2024 Aug; 37(4):304-311. PubMed ID: 38779903
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drugs in acute viral respiratory tract infections: An updated systematic review.
Azh N; Barzkar F; Motamed-Gorji N; Pourvali-Talatappeh P; Moradi Y; Vesal Azad R; Ranjbar M; Baradaran HR
Pharmacol Res Perspect; 2022 Apr; 10(2):e00925. PubMed ID: 35218614
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence.
Yousefifard M; Zali A; Zarghi A; Madani Neishaboori A; Hosseini M; Safari S
Int J Clin Pract; 2020 Sep; 74(9):e13557. PubMed ID: 32460369
[TBL] [Abstract][Full Text] [Related]
4. Ibuprofen, other NSAIDs and COVID-19: a narrative review.
Laughey W; Lodhi I; Pennick G; Smart L; Sanni O; Sandhu S; Charlesworth B
Inflammopharmacology; 2023 Oct; 31(5):2147-2159. PubMed ID: 37603158
[TBL] [Abstract][Full Text] [Related]
5. NSAIDs and COVID-19: A Systematic Review and Meta-analysis.
Moore N; Bosco-Levy P; Thurin N; Blin P; Droz-Perroteau C
Drug Saf; 2021 Sep; 44(9):929-938. PubMed ID: 34339037
[TBL] [Abstract][Full Text] [Related]
6. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
7. The COVID-19 ibuprofen controversy: A systematic review of NSAIDs in adult acute lower respiratory tract infections.
Vaja R; Chan JSK; Ferreira P; Harky A; Rogers LJ; Gashaw HH; Kirkby NS; Mitchell JA
Br J Clin Pharmacol; 2021 Mar; 87(3):776-784. PubMed ID: 32805057
[TBL] [Abstract][Full Text] [Related]
8. Strategies Tackling Viral Replication and Inflammatory Pathways as Early Pharmacological Treatment for SARS-CoV-2 Infection: Any Potential Role for Ketoprofen Lysine Salt?
Mariniello DF; Allocca V; D'Agnano V; Villaro R; Lanata L; Bagnasco M; Aronne L; Bianco A; Perrotta F
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558048
[TBL] [Abstract][Full Text] [Related]
9. Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials.
Yao J; Zhang Y; Wang XZ; Zhao J; Yang ZJ; Lin YP; Sun L; Lu QY; Fan GJ
Front Public Health; 2022; 10():814669. PubMed ID: 35252093
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19.
Robb CT; Goepp M; Rossi AG; Yao C
Br J Pharmacol; 2020 Nov; 177(21):4899-4920. PubMed ID: 32700336
[TBL] [Abstract][Full Text] [Related]
11. Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization.
Abo Elmaaty A; Hamed MIA; Ismail MI; B Elkaeed E; S Abulkhair H; Khattab M; Al-Karmalawy AA
Molecules; 2021 Jun; 26(12):. PubMed ID: 34205704
[TBL] [Abstract][Full Text] [Related]
12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
13. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
Lund LC; Kristensen KB; Reilev M; Christensen S; Thomsen RW; Christiansen CF; Støvring H; Johansen NB; Brun NC; Hallas J; Pottegård A
PLoS Med; 2020 Sep; 17(9):e1003308. PubMed ID: 32898149
[TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection.
Chen JS; Alfajaro MM; Chow RD; Wei J; Filler RB; Eisenbarth SC; Wilen CB
J Virol; 2021 Mar; 95(7):. PubMed ID: 33441348
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs (NSAIDs) consideration by dermatologists during the COVID19 pandemic.
Elsaie ML; Jafferany M; Jorgaqi E
J Dermatolog Treat; 2022 Mar; 33(2):1134-1135. PubMed ID: 32723104
[TBL] [Abstract][Full Text] [Related]
16. Risk of SARS-CoV-2 Infection and COVID-19 Severity Associated With Exposure to Nonsteroidal Anti-Inflammatory Drugs: Systematic Review and Meta-Analysis.
Prada L; D Santos C; Baião RA; Costa J; Ferreira JJ; Caldeira D
J Clin Pharmacol; 2021 Dec; 61(12):1521-1533. PubMed ID: 34352112
[TBL] [Abstract][Full Text] [Related]
17. The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19.
Kushner P; McCarberg BH; Grange L; Kolosov A; Haveric AL; Zucal V; Petruschke R; Bissonnette S
NPJ Prim Care Respir Med; 2022 Sep; 32(1):35. PubMed ID: 36127354
[TBL] [Abstract][Full Text] [Related]
18. NSAIDs and Kelleni's protocol as potential early COVID-19 treatment game changer: could it be the final countdown?
Kelleni MT
Inflammopharmacology; 2022 Feb; 30(1):343-348. PubMed ID: 34822026
[TBL] [Abstract][Full Text] [Related]
19. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
Capuano A; Scavone C; Racagni G; Scaglione F;
Pharmacol Res; 2020 Jul; 157():104849. PubMed ID: 32360482
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
